Trial intelligence / Profile preview

Autologous Limbal Stem Cell Transplantation for Corneal Repair

NCT02148016Phase 2Unknown

Sponsor
Sun Yat-sen University
Start
Dec 2012
Primary completion
Jun 2014
Modality
Stem Cell Therapies
Countries
1
01

Overview

Phase 2, randomised, open-label trial in corneal disease, pterygium, myopia and 1 more (4 arms), sponsored by Sun Yat-sen University. Primary endpoint: Composite measure of visual function at 1 year. Status: unknown.

02

Conditions

corneal diseasepterygiummyopiaHyperopia

Beyond the preview

Go deeper on NCT02148016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02148016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call